Skip to main content

Table 3 Relationships between the expressions of the immune-related genes and the clinicopathological factors in LUSC

From: Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis

Gene symbol Age (65/< 65) Gender (male/female) Stage (I&II/III&IV) T stage (T1–T2/T3–T4) M stage (M0/M1) N stage (N0/N1-3)
t P t P t P t P t P t P
CXCL5 0.391 0.696 − 1.302 0.194 −  0.972 0.334 − 1.108 0.271 0.58 0.583 − 0.7 0.485
MMP12 − 2.276 0.023 1.365 0.174 0.518 0.605 2.307 0.022 0.25 0.812 − 0.927 0.355
PLAU − 2.427 0.016 0.101 0.92 0.547 0.585 − 2.346 0.021 0.032 0.975 2.492 0.013
ELN − 1.893 0.059 2.107 0.037 − 0.21 0.834 − 0.143 0.886 2.591 0.031 0.397 0.691
JUN − 2.521 0.012 1.592 0.113 − 0.353 0.725 − 1.425 0.158 − 0.619 0.559 1.089 0.277
RNASE7 − 0.113 0.91 0.372 0.71 2.42 0.016 − 0.596 0.553 3.296 0.007 0.094 0.926
JAG1 − 0.625 0.532 − 1.557 0.121 − 0.903 0.369 − 0.85 0.398 − 1.501 0.189 − 0.837 0.404
SPP1 0.261 0.794 − 1.242 0.216 − 0.855 0.395 0.131 0.896 0.133 0.899 0.936 0.35
AGTR2 − 0.707 0.48 0.086 0.932 1.931 0.054 − 0.009 0.993 2.317 0.036 3.376 8.28E−04
FGFR4 1.423 0.156 − 2.509 0.013 − 0.89 0.376 0.632 0.528 9.289 7.33E−14 − 1.725 0.086
TNFRSF18 1.752 0.081 − 0.933 0.352 − 0.29 0.773 − 0.24 0.811 0.077 0.941 − 0.81 0.419
riskScore − 2.79 0.006 0.267 0.79 − 0.596 0.553 − 1.255 0.213 1.597 0.159 1.188 0.236